XWXingbang Wang

Xingbang Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xingbang Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthesis of bamboo-like SiC nanowires with controllable densities of bamboo nodes

    by Binbin Li, Bangxiao Mao, Tao He, Xingbang Wang, Haiquan Huang

    Herein, bamboo-like SiC nanowires were synthesized via the atmospheric pressure chemical vapor deposition (APCVD) approach. The mixed powders of polycarbosilane (PCS) and activated carbon (AC) were used as the raw materials. Particularly, the pyrolysis rate of the raw materials were controlled by adjusting the proportion of activated carbon. The reaction gas was periodically changed by placing raw materials in two different temperature zones. Subsequently, bamboo-like SiC nanowires with different densities of bamboo nodes were obtained in the way of adjusting the time of periodic change in the concentration of the reaction gas. The morphologies and microstructure of the bamboo-like nanowires were investigated by X-ray diffraction, scanning electron microscope, and high resolution transmission electron microscopy as well as selected area electron diffraction. Finally, the growth process of the bamboo-like SiC nanowires was investigated from the perspective of the root vapor-liquid-solid (VLS) mechanism as well as the periodic change in concentration.


  • Open Access

    Minocycline Protects against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson’s Disease Rat Model

    by Congcong Sun, Yun Wang, Mingshu Mo, Chengyuan Song, Xingbang Wang, Si Chen, Yiming Liu

    The aim of this study was to investigate the effect of minocycline in rats with rotenone-induced Parkinson’s disease (PD). The open field test was performed to determine the motor ability of the rats. Double immunofluorescence staining was used to detect the expression of tyrosine hydroxylase (TH) and Nurr1 in the substantia nigra (SN) of rats. The relative protein levels of TH, Nurr1, and the total- and phosphorylated-cAMP-response element binding protein (CREB) were determined by western blot analysis. The production of reactive oxygen species (ROS) and nitric oxide (NO) was detected by commercial kits. After exposure to rotenone for 28 days, rats exhibited decreased ambulation and rearing frequency and prolonged immobility time with loss of TH positive neurons in the SN. The phosphorylation levels of CREB and Nurr1 expression decreased significantly accompanied with the release of ROS and NO. Minocycline alleviated the motor deficits of rats lesioned by rotenone and elevated the expression of TH, as well as suppressing the release of ROS and NO in the SN. That was in line with the elevated phosphorylation levels of CREB and Nurr1 expression. In conclusion, our present study showed minocycline protected against neurotoxicity in a rotenone-induced rat model of PD, which was correlated with upregulation of Nurr1.